K.H. Lee
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 5
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 12
- Advanced Breast Cancer Therapies 3
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Kazuhiko Nakagawa (6 shared papers)Shunichi Sugawara (3 shared papers)Yuichiro Ohe (4 shared papers)Toyoaki Hida (2 shared papers)Naoki Inui (2 shared papers)Hye Ryun Kim (2 shared papers)Cheng‐Ta Yang (2 shared papers)Makoto Nishio (2 shared papers)
- Journals
- Annals of Oncology (12 papers)Journal of Thoracic Oncology (2 papers)IEEE Transactions on Power Delivery (1 paper)ESMO Open (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
K.H. Lee
17 papers receiving 393 citations
K.H. Lee's Hit Papers
Peers
Comparison fields: 5 of 34
- Oncology 279
- Pulmonary and Respiratory Medicine 175
- Cancer Research 41
- Immunology 30
- Pathology and Forensic Medicine 10
Countries citing papers authored by K.H. Lee
This map shows the geographic impact of K.H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.H. Lee more than expected).
Fields of papers citing papers by K.H. Lee
This network shows the impact of papers produced by K.H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.H. Lee. The network helps show where K.H. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside K.H. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 142 | |
| 2 | 2018 | 74 | |
| 3 | 2019 | 43 | |
| 4 | LBA1 Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: Final results from PACIFIC-2 Hit paper breakdown → | 2024 | 43 |
| 5 | 2017 | 20 | |
| 6 | 2021 | 15 | |
| 7 | 2020 | 14 | |
| 8 | 2022 | 9 | |
| 9 | 1989 | 8 | |
| 10 | 2019 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2019 | 5 | |
| 13 | 2023 | 2 | |
| 14 | 2017 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2021 | 1 |
About K.H. Lee
K.H. Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Astronomy and Astrophysics, having authored 17 papers that have together received 394 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Research Studies (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Advanced Breast Cancer Therapies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Oncology (279 citations), Pulmonary and Respiratory Medicine (175 citations), Cancer Research (41 citations), Immunology (30 citations) and Pathology and Forensic Medicine (10 citations). K.H. Lee has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Kazuhiko Nakagawa, Shunichi Sugawara, Yuichiro Ohe, Toyoaki Hida, Naoki Inui, Hye Ryun Kim, Cheng‐Ta Yang, Makoto Nishio, Tomohide Tamura and Chong‐Jen Yu. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, IEEE Transactions on Power Delivery, ESMO Open and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.